Corbus Pharmaceuticals (CRBP) PT Raised to $40 at Mizuho
Mizuho analyst Graig Suvannavejh raised the price target on Corbus Pharmaceuticals (NASDAQ: CRBP) to $40.00 (from $39.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)